Regarding the metabolic features of NAFLD, we confirmed that FFD mice gained more weight and had higher glucose, cholesterol, insulin and liver function tests at the endpoint compared to CD mice. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.